3, 4-Dehydro Cilostazol b N-oxide Smiles: CC1C=CC(=CC=1)S(=O)(=O)NC1=CC=CC=C1C=NC1=CC=CC=C1NS(=O)(=O)C1C=CC(C)=CC=1

Smiles: CC1C=CC(=CC=1)S(=O)(=O)NC1=CC=CC=C1C=NC1=CC=CC=C1NS(=O)(=O)C1C=CC(C)=CC=1

PF-5274857 is a potent

CDK12-IN-6 has no effect on CDK2/Cyclin E (IC50>20 μM) and CDK9/Cyclin T1 (IC50>20 μM) at high ATP (2 mM) (WO2021116178A1)

DLin-MC3-DMA exhibits an optimized pKa value that leads to dramatically enhanced potency

InChiKey: HRSANNODOVBCST-UHFFFAOYSA-N

3, 4-Dehydro Cilostazol b N-oxide Smiles: CC1C=CC(=CC=1)S(=O)(=O)NC1=CC=CC=C1C=NC1=CC=CC=C1NS(=O)(=O)C1C=CC(C)=CC=13,4 Dehydro Cilostazol (OPC 13015) is an active metabolite of Cilostazol (CLZ; HY 17464). 3,4 Dehydro Cilostazol is used for pharmacokinetic study. Product information CAS Number: 73963 62 9 Molecular Weight: 367. 44 Formula: C20H25N5O2 Chemical Name: 6 [4 (1 cyclohexyl 1H 1,2,3,4 tetrazol 5 yl)butoxy] 1,2 dihydroquinolin 2 one Smiles: O=C1C=CC2=CC(=CC=C2N1)OCCCCC1=NN=NN1C1CCCCC1 InChiKey: GHALECSGOJQOHW UHFFFAOYSA N InChi: InChI=1S C20H25N5O2 c26 20